Your new post is loading...
The project "CardioWheel: Upscaling the Production of Human Pluripotent Stem Cell-derived Cardiomyocytes using Vertical-Wheel Bioreactors" has been recommended for funding by FCT (2017 Call for SR&TD Project Grants). The goal of CardioWheel is the application of bioreactor technology for human Pluripotent Stem Cell expansion and cardiomyocyte differentiation in a single process, culturing cells in suspension in the novel single-use Vertical-Wheel Bioreactors. These bioreactors will be characterized using computational fluid dynamics and this knowledge will be used to scale up the culture. The generated cells will be tested for functional and pharmacological activity to demonstrate their applicability in drug discovery and regenerative medicine. The project, which falls within the scientific area of Chemical Engineering, is headed by Carlos Rodrigues and Joaquim Cabral from SCERG-iBB.
